Replies to post #173580 on Biotech Values

[GrthzGd]

ABBV/ENTA BID vs. GILD QD. Not to nauseate, but this study disputes the assumption of QD's real world superiority in any event: Estimation of the comparative therapeutic superiority of QD and BID dosing regimens, based on integrated analysis of dosing history data and pharmacokinetics..